Javier, Esterlita L.

HRN: 03-08-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/27/2023
10/04/2023
IVT
600 Mg
Q8hrs
ABSCESS
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: